Key Stats for Astera Labs Stock
- Current Price: $291.22
- Target Price (Mid): ~$715
- Street Target: ~$390
- Potential Total Return: ~146%
- Annualized IRR: ~23% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Astera Labs (ALAB) sells the switching and signal-conditioning chips that let racks of AI accelerators behave like one machine. Investors already knew the headline: on August 4, the company said its Scorpio switching family would become its largest product line by revenue in the third quarter, a quarter ahead of its prior plan. What the market did not have until Citi’s Global TMT Conference on September 9 was the shape of the ramp behind that promise. CFO Desmond Lynch said Scorpio X customer engagements have grown from an initial 10 to the high teens, with several expected to convert to design wins by year-end and contribute revenue in 2027.
Shares traded near $320 on September 4 on speculation that ALAB would join the S&P 500, then gave most of it back after the index committee passed the company over and named Bloom Energy, Illumina, and Everpure instead. ALAB closed at $291.22 on September 11.
The Switch That Changes How Much Astera Earns Per Rack
Scorpio X, the 320-lane fabric switch launched in May, moves Astera into the center of the AI rack, connecting GPUs so software can address dozens of them as a single unit. That is a richer position than the retimers the company built its business on: content per accelerator started below $100 in the retimer era and now sits close to $1,000 across the portfolio, with Scorpio X alone on track for $1,000 or more per accelerator.
Mohan confirmed it entered volume production in the current quarter and will overtake Scorpio P within the Scorpio family, even though Scorpio P was itself the fastest-growing product line the company had ever shipped. That ramp is the main reason Q3 revenue was guided to $540 million to $560 million, roughly 40% above the June quarter at the midpoint.
What makes Scorpio X hard to copy is what Astera built around it. A GPU wired to a Scorpio X produces more tokens per second than the same GPU on a generic PCIe switch, thanks to in-network compute features designed for AI workloads. When compute supply cannot keep up with demand, more output from the same silicon is worth real money to a hyperscaler. Competition will come, and Mohan welcomed it plainly, but the switching platform is a foothold: once a customer standardizes on it, Astera influences every signal-conditioning decision downstream. The economics even cut Astera’s way as clusters grow. Mohan noted that contrary to popular belief, price per lane rises rather than falls as switch radix increases, so bigger clusters lift average selling prices rather than compress them.
See historical and forward estimates for Astera Labs stock (It’s free!) >>>
The Roadmap the Index Traders Ignored
Astera is opening two adjacent fronts. The first is optical: through its acquisition of aiXscale Photonics, completed in January 2026, the company gains a glass connector that some customers are already qualifying, with first component-level optical revenue expected in 2027 and a path toward a co-packaged optical engine where Astera supplies the electrical IC, the photonics IC, and the fiber-attach packaging.
The second front is protocol breadth. Astera is already active in NVIDIA’s NVLink Fusion, ships PCIe-based solutions today, and is building toward UALink, the fabric AMD favors for its MI450-series systems. The NVLink Fusion engagement is the quieter tell. Mohan framed it as “a great sign of NVIDIA trusting us to deploy the NVLink infrastructure with other customers,” which is not a role a peripheral supplier is handed.
On margins, CFO Desmond Lynch said gross margin, now in the mid-70s, will trend toward the company’s 70% long-term target as module and Scorpio X mix grow, healthy for a product semiconductor business, but a drift down from today. The sharper risk is concentration: Lynch acknowledged at Citi that with the company shipping to every US hyperscaler, customer concentration “is to be expected,” and the lead customer is still the largest by far, even as Scorpio P and Scorpio X engagements broaden. A single hyperscaler trimming its buildout would land hard on near-term revenue.
ALAB trades near 41 times trailing enterprise value to revenue and about 143 times trailing earnings, multiples that only work if the growth Astera describes shows up. Against peers, the premium is stark: on forward EV/revenue, NVIDIA sits near 10x and Broadcom near 11x, while Astera is almost 19x, per TIKR’s Competitors data. The 104% year-over-year revenue growth Astera posted last quarter is why that premium is not baseless, but it leaves no room for a stumble, and the 60% drawdown earlier in 2026 shows how fast a stock this richly valued can reprice.
See how Astera Labs performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $291.22
- Target Price (Mid): ~$715
- Potential Total Return: ~146%
- Annualized IRR: ~23% / year
See analysts’ growth forecasts and price targets for Astera Labs stock (It’s free!) >>>
The mid case is the honest one, because it does not lean on the highest assumptions to make the stock look cheap. Two revenue drivers anchor it: the Scorpio X ramp lifting content per accelerator into four-figure territory, and the optical and UALink expansion opening new attach points from 2027. The margin driver is operating leverage as switching volume scales, with net income margin modeled around 40% in the mid case. The primary risk is the multiple: the model assumes modest P/E compression each year, and if it runs faster, the return shrinks quickly.
- Upside: if Scorpio X holds share and optical arrives on schedule, the model’s higher scenarios push the 2030 target well above the mid case.
- Downside: a slower ramp or sharper valuation reset leaves a buyer at $291 waiting years to break even, the same round trip the stock ran between June and September.
Conclusion
The next test is the Q3 print, guided to $540 million to $560 million. Watch two things: whether the Scorpio family shows up as the largest revenue contributor as promised, with Scorpio X leading it, and whether gross margin holds in the mid-70s rather than sliding early toward the 70% target. A clean beat with Scorpio confirmed as the revenue leader tells you the ramp is real and on schedule. A guide leaning on the lead customer alone, or margin slipping faster than mix explains, would say the ramp is narrower than the story. The report should land in early November, based on last year’s November 4 Q3 date. Until then, the index trade is dead and the fundamentals are back in charge.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Astera Labs?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Astera Labs, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Astera Labs alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Astera Labs on TIKR Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
